GlassScriptPhysician profile
Bruce N Terrin
NPI 1528090081
$3,178.88
in general payments reported to CMS, 2019-2025
19 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $1,598 · 2021: $133 · 2022: $188 · 2023: $251 · 2024: $364 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,790.74 | 2019-2025 | |
| Glaxosmithkline, LLC. | $193.13 | 2022-2025 | Bexsero, Rotarix, Penmenvy |
| Sanofi-Aventis U.S. LLC | $186.90 | 2024-2025 | |
| Emmaus Medical, INC. | $176.98 | 2019-2024 | Endari |
| Qiagen, LLC | $160.95 | 2019-2021 | |
| Sanofi Pasteur INC. | $149.68 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $127.22 | 2023-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Kyowa Kirin, INC. | $75.43 | 2025 | |
| Sobi, INC | $69.02 | 2019-2023 | |
| Alk-Abello, INC | $47.31 | 2025 | Neffy |
| Cranial Technologies, INC | $41.32 | 2020-2023 | Doc Band |
| Seqirus USA INC | $34.94 | 2024-2025 | Flucelvax |
| Cumberland Pharmaceuticals, INC. | $30.08 | 2023 | Kristalose |
| Rare Disease Therapeutics, INC. | $22.75 | 2025 | Xromi |
| Medunik USA INC. | $15.61 | 2024 | Siklos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.99 | 2020 | |
| Phadia US INC. | $14.51 | 2019 | |
| Genentech USA, INC. | $14.24 | 2019 | |
| Aytu Biopharma, INC. | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Terrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.